Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.
about
Herpes simplex virus and varicella zoster virus, the house guests who never leaveQ24202587Targeted DNA mutagenesis for the cure of chronic viral infectionsThe interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathwaysThe role of infection in miscarriageHerpes simplex virus type 1 latency and reactivation: an updateThe molecular basis of herpes simplex virus latencyEpigenetic regulation of latent HSV-1 gene expression.Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinDetection of the genome and transcripts of a persistent DNA virus in neuronal tissues by fluorescent in situ hybridization combined with immunostaining.Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured ratsLytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional responseHerpes keratitis.LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans.Tegument protein control of latent herpesvirus establishment and animation.Spread of herpes simplex virus to the spinal cord is independent of spread to dorsal root ganglia.Characterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection.Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype.Varicella-zoster virus (VZV) infection of neurons derived from human embryonic stem cells: direct demonstration of axonal infection, transport of VZV, and productive neuronal infection.A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro.Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal modelsEvasion of early antiviral responses by herpes simplex viruses.A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesisHerpes and polyoma family viruses in thyroid cancer.Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.Role of immediate early protein ICP27 in the differential sensitivity of herpes simplex viruses 1 and 2 to leptomycin BOcular HSV-1 latency, reactivation and recurrent disease.Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice.Bovine herpesvirus 1 regulatory proteins bICP0 and VP16 are readily detected in trigeminal ganglionic neurons expressing the glucocorticoid receptor during the early stages of reactivation from latency.Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia.Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.Latency-associated transcript (LAT) exon 1 controls herpes simplex virus species-specific phenotypes: reactivation in the guinea pig genital model and neuron subtype-specific latent expression of LATFSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia.Evolutionary-developmental perspectives on immune system interactions among the pregnant woman, placenta, and fetus, and responses to sexually transmitted infectious agents.Control of HSV-1 latency in human trigeminal ganglia--current overview.Animal models of herpes simplex virus immunity and pathogenesis.An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.
P2860
Q21195896-1FB65070-FFBA-496C-B9DD-9E934817AD4BQ24202587-40D708FD-61F0-471C-96A8-B0BDAEDDCA93Q24620150-5A08EA30-9E9A-4156-95AC-266688C81D93Q26751441-DAEB6C38-840C-460D-B3F6-1BBC20F5D3F8Q26783142-96FDC610-04E6-4F83-A13B-56ACE30282DBQ26866072-EB021D9E-79A8-4ECF-B565-A10C422C2105Q27001272-E025AD28-D41B-440C-A8C3-C18C03BA957CQ33729340-EF6B2220-E52B-479F-B7C5-1623E5B7DC15Q33792025-A1705E07-EC29-4DB1-8058-2035AE6D2C70Q33872977-B563390D-4CA9-4F50-A804-A2DA2B5D991FQ33895720-7A9B336C-A697-41A0-970B-0BAA8668A87EQ33946164-0BCA0765-04EB-4B66-9037-545709E7B458Q34297293-65C9C10D-4062-438B-B76E-863649366AB2Q34541841-9D413692-CF5E-4A7E-905E-AE9FA99EA731Q34712750-46DBCCFA-B73E-432D-8694-16927E948EBFQ34742908-08FB6007-8D05-4476-9763-534B0B445B95Q35075587-013032A5-4B74-4075-8462-D056368398D4Q35076893-C6AD2C48-A8DD-4625-B67F-2600E059F836Q35077427-BC3442A0-D812-4B40-888D-95A3778C5649Q35077500-E2041C89-8E31-4DD6-A132-F088E73127B7Q35168425-5C4964F0-6292-4E8A-AA46-862B2C8DFAA5Q35271194-A24097BC-0574-412C-A86D-8601376F08F5Q35414669-7924A30A-F3D0-4E7E-BB1C-2A9FA8B120C6Q36397612-03B1BB3C-32D1-41B2-8A24-ECF7A91B00B2Q36607105-E8F35EEA-2305-49DB-BC47-4281953AA901Q36640448-F716E750-FC10-4763-B287-9DD01D0CBC46Q37061759-33129AF2-D3FB-4464-8AFE-E3D63CF19D98Q37123285-AC03F75B-338C-4248-ACEF-3AF18C9CCB60Q37201603-44FC9AC0-5FC0-4EA7-81AB-4EBB3900CF44Q37217736-86354843-DDCE-4BB2-BA56-372BA8147CB8Q37252555-638B3FCA-CE59-4625-901E-052086801A1EQ37275033-257F7EA7-609B-4527-B050-FA67F60D01BDQ37329754-61F44DF7-B461-430C-B9E3-776307ECF15DQ37356051-AA5FA9A9-917D-4AF3-96F7-5F0002E54F71Q37428262-FC37B87B-0F20-4075-9E39-22CA75B1352FQ37435593-17E92BAC-C42C-4AFD-AA24-8A4486A5B078Q37913474-525F24CB-CB25-466F-87B6-D710C494DCCDQ37964558-8BBF5D17-40C5-44AC-8C86-3AF495053FDDQ38267269-FDA8A649-67F5-4C4E-9430-9B326AEAEDF8Q38707911-B16CC00C-319C-43AD-A3A8-8A8BAEA8BE48
P2860
Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@ast
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@en
type
label
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@ast
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@en
prefLabel
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@ast
Herpes simplex virus type 2 (H ...... atency-associated transcripts.
@en
P2093
P2860
P356
P1433
P1476
Herpes simplex virus type 2 (H ...... latency-associated transcripts
@en
P2093
Todd P Margolis
Vicky Vallas
P2860
P304
P356
10.1128/JVI.02110-06
P407
P577
2006-12-06T00:00:00Z